Learn More
Apexbio Technology LLC Ercalcitriol 60133-18-8 25mg

Supplier: Apexbio Technology LLC A339625
Ercalcitriol (60133-18-8) is a small-molecule agonist targeting the vitamin D receptor (VDR) It is designed to modulate VDR-mediated pathways thereby regulating calcium and phosphorus metabolism Ercalcitriol exerts its biological activity primarily through binding to VDR and initiating transcriptional regulation processes In preclinical studies Ercalcitriol demonstrates activity in the regulation of calcium homeostasis and bone mineralization Based on these pharmacological properties Ercalcitriol holds research potential in the investigation of VDR signaling calcium metabolism bone mineralization and potential therapeutic effects in models of rickets and related bone metabolism disorders
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.